NCT01205191

Brief Summary

Definitions CBT-ubiquitous - Cognitive behavioural therapy (CBT) provided with all-time (ubiquitous) support by cell phone applications CBT-TAU - Cognitive behavioural Therapy provided 'As Usual' CBT-placebo - Cognitive behavioural therapy provided with access to a digital audio player with self-administered materials for stress management and relaxation. Study objectives

  1. 1.to compare the relative effectiveness of a computerized ubiquitous CBT (CBT-ubiquitous) against anxiety disorders with CBT-treatment as usual (CBT-TAU);
  2. 2.to assess the safety and tolerability of the CBT-ubiquitous as compared with CBT-TAU and CBT provided with access to a placebo technical device (CBT-placebo)..

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for phase_2 anxiety

Timeline
Completed

Started Apr 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 20, 2010

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

June 15, 2011

Status Verified

September 1, 2010

Enrollment Period

1.2 years

First QC Date

September 16, 2010

Last Update Submit

June 14, 2011

Conditions

Keywords

Cognitive behavioural therapyAnxietyPrimary careEffectiveness trialCell-phone supported therapy

Outcome Measures

Primary Outcomes (1)

  • Anxiety

    Hospital Anxiety and Depression Scale-Anxiety (HADS-A), General Health Questionnaire-12 (GHQ-12), Beck's Anxiety Index (BAI)

    Six months after treatment

Secondary Outcomes (1)

  • Adherence

    14 weeks

Study Arms (3)

CBT-ubiquitous

EXPERIMENTAL
Behavioral: Cell-phone supported CBT

CBT-placebo

PLACEBO COMPARATOR

Cognitive behavioural therapy provided with access to a digital audio player with self-administered materials for stress management

Behavioral: CBT with digital audio player support

CBT-TAU

ACTIVE COMPARATOR

Cognitive behavioural Therapy provided 'As Usual'

Behavioral: CBT

Interventions

Cognitive behavioural therapy provided with all-time (ubiquitous) support by cell phone applications

CBT-ubiquitous

Cognitive behavioural therapy provided with access to a digital audio player with self-administered materials for stress management and relaxation.

CBT-placebo
CBTBEHAVIORAL

CBT for anxiety disorders

CBT-TAU

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age 18 to 25; and
  • scoring 7 or higher on the anxiety section of the Hospital Anxiety and Depression scale (HADS) at initial evaluation.

You may not qualify if:

  • at the initial evaluation displays symptoms indicative for referral to a psychiatric specialist, e.g. active suicidal ideas or symptoms of a psychotic disorder, organic mental disorder or alcohol and/or drug dependence; or
  • is unable to read, write or speak in the Swedish;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Unga Vuxna" Clinic

Linköping, Östergötland County, SE58185, Sweden

RECRUITING

Related Publications (1)

  • Ekberg J, Timpka T, Bang M, Froberg A, Halje K, Eriksson H. Cell phone-supported cognitive behavioural therapy for anxiety disorders: a protocol for effectiveness studies in frontline settings. BMC Med Res Methodol. 2011 Jan 10;11:3. doi: 10.1186/1471-2288-11-3.

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Toomas Timpka, MD PhD

    Section of Social Medicine/LiU

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 16, 2010

First Posted

September 20, 2010

Study Start

April 1, 2011

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

June 15, 2011

Record last verified: 2010-09

Locations